Medical Device News Magazine

STAAR Surgical Appoints Dr. Elizabeth Yeu and Dr. K. Peony Yu to the Board of Directors: Effective January 21, 2021

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

January 26, 2021

Staar Surgical Chairman of the Staar Surgical Board Nominating and Governance Committee said, “The addition of Dr. Elizabeth Yeu and Dr. K. Peony Yu to our Board of Directors illustrates STAAR’s commitment to excellence, the surgeon community and growth.”

He notes, “Elizabeth is a renowned, highly-respected ophthalmic surgeon, and thought leader within the Ophthalmology community. For several years, she has served as a member of the Executive Committee of the American Society of Cataract and Refractive Surgery. Peony is an accomplished physician and healthcare executive who, with more than 25 years of biomedical leadership and patient care experience, has led key clinical programs and global product approvals. Elizabeth and Peony collectively bring a wealth of additional clinical, business and growth perspectives, and we are delighted to have both doctors join STAAR’s Board.”

“As we pursue our strategic imperative of leading the lens-based future of refractive vision correction, I couldn’t be more thrilled to have Elizabeth and Peony join our Board,” said Caren Mason, President and CEO of STAAR Surgical. “Their significant medical and industry expertise will provide valuable contributions as we aim to facilitate visual freedom for patients with our EVO family of implantable Collamer® lenses, accelerate our company’s growth and capture refractive market share, globally.”

STAAR also reported today that Mr. John Moore, who has served as a member of the Board of Directors since 2008, has chosen to retire from the Board of Directors when his current term expires, effective at STAAR’s 2021 Annual Shareholders Meeting. Mr. Silverman, STAAR’s chairman of the Board of Directors, said, “John’s contributions to STAAR over the past 12 years have been significant and meaningful. We relied on John’s technical expertise, and have valued his insights in shaping the company’s growth and supporting STAAR’s leadership team. The entire Board is thankful for John’s service to STAAR and wish John and his family all the best following his retirement.”

The other current members of STAAR’s Board of Directors include Stephen Farrell, Thomas Frinzi, Gilbert Kliman, M.D., Caren Mason, and Louis Silverman.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”